VICTORIA SANFORD: Open Payments
NPI 1568013993 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,127 in 263 payments from 19 companies in 2025. Trend: 2023 $2,412 · 2024 $2,664 · 2025 $4,127
Food & beverage: $4,006Education: $121
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 32 | $593 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 43 | $495 |
| Alkermes, Inc. | 27 | $472 |
| ABBVIE INC. | 37 | $458 |
| Otsuka America Pharmaceutical, Inc. | 23 | $374 |
| Axsome Therapeutics, Inc. | 20 | $342 |
| E.R. Squibb & Sons, L.L.C. | 17 | $254 |
| Teva Pharmaceuticals USA, Inc. | 11 | $246 |
| Vanda Pharmaceuticals Inc. | 14 | $218 |
| Lundbeck LLC | 10 | $189 |
Products named: INGREZZA, REXULTI, CAPLYTA, VRAYLAR, ARISTADA, Auvelity, COBENFY, FANAPT.
Industry payments across MO — which companies pay providers there.
